Biomarker: E215-IgE Pigeon Feathers

Overview

E215-IgE Pigeon Feathers measures serum immunoglobulin E (IgE) antibodies directed against pigeon-feather allergens. IgE can bind to mast cells and basophils and trigger the release of inflammatory mediators involved in immediate allergic reactions. A detectable or elevated result indicates sensitization to the tested pigeon-feather extract, but it does not by itself confirm symptomatic allergy or predict reaction severity. The test is clinically useful when interpreted with exposure history and symptoms such as allergic rhinitis, conjunctivitis, asthma, or other respiratory reactions associated with pigeons or feather dust.

Clinical Use Cases

Evaluate suspected IgE-mediated sensitization to pigeon feathers in people with compatible symptoms.
Support assessment of occupational or recreational exposure in pigeon breeders, bird handlers, and other frequently exposed individuals.
Help investigate bird-associated rhinitis, asthma, or immediate respiratory reactions when skin testing is unsuitable or unavailable.
Identify possible sensitization to pigeon-feather allergens that may cross-react with allergens from other bird species.
Complement, but not replace, clinical history, physical examination, and other allergy investigations.

Specimen Types

Venous blood, processed to obtain serum.
Serum is the typical specimen for allergen-specific IgE measurement.

Measurement Methods

Fluorescent enzyme immunoassay or other automated solid-phase immunoassays.
Enzyme-linked immunosorbent assay (ELISA).
Radioallergosorbent testing (RAST), mainly in historical research or older laboratory methods.
Immunoblotting and related research assays for characterizing pigeon-feather allergen components.

Test Preparation and Influencing Factors

Fasting is generally not required for an allergen-specific IgE blood test.
Tell the healthcare professional about all medications and supplements. Do not stop medications unless specifically instructed.
Antihistamines that interfere with skin testing generally do not prevent collection of a blood sample, but medication effects should still be reviewed with the ordering clinician.
Results should be interpreted with symptoms, timing of exposure, exposure intensity, and other allergy-test findings.
A positive result indicates sensitization and does not establish that pigeon feathers caused symptoms or indicate how severe a future reaction may be.
False-positive results may occur because of cross-reactivity or clinically irrelevant sensitization. Pigeon-feather allergens may share reactive components with allergens from other birds and feather-associated organisms.
Total IgE, smoking, parasitic infection, age, and other allergic conditions may affect overall IgE interpretation but do not specifically establish pigeon-feather allergy.